Reflex T790M testing for all EGFRm NSCLC patients progressing on 1G/2G EGFR TKI is of utmost importance for further treatment strategy, because no well-defined clinical characteristics are representative for the development of this resistance mutation [31,32]. Here, EGFR is linked to non-small cell lung carcinoma.